- Home
- KLTO vs EVOK Comparison
KLTO vs EVOK Comparison
Compare KLTO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- EVOK
- Stock Information
- Founded
- KLTO 2019
- EVOK 2007
- Country
- KLTO United States
- EVOK United States
- Employees
- KLTO N/A
- EVOK N/A
- Industry
- KLTO
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- KLTO
- EVOK Health Care
- Exchange
- KLTO NYSE
- EVOK Nasdaq
- Market Cap
- KLTO 5.0M
- EVOK 4.2M
- IPO Year
- KLTO N/A
- EVOK 2013
- Fundamental
- Price
- KLTO $0.16
- EVOK $2.59
- Analyst Decision
- KLTO
- EVOK
- Analyst Count
- KLTO 0
- EVOK 0
- Target Price
- KLTO N/A
- EVOK N/A
- AVG Volume (30 Days)
- KLTO 152.3K
- EVOK 16.5K
- Earning Date
- KLTO 05-15-2025
- EVOK 05-13-2025
- Dividend Yield
- KLTO N/A
- EVOK N/A
- EPS Growth
- KLTO N/A
- EVOK N/A
- EPS
- KLTO N/A
- EVOK N/A
- Revenue
- KLTO N/A
- EVOK $10,249,415.00
- Revenue This Year
- KLTO N/A
- EVOK $58.84
- Revenue Next Year
- KLTO N/A
- EVOK $58.11
- P/E Ratio
- KLTO N/A
- EVOK N/A
- Revenue Growth
- KLTO N/A
- EVOK 97.84
- 52 Week Low
- KLTO $0.11
- EVOK $1.94
- 52 Week High
- KLTO $13.10
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- EVOK 47.70
- Support Level
- KLTO N/A
- EVOK $2.02
- Resistance Level
- KLTO N/A
- EVOK $2.53
- Average True Range (ATR)
- KLTO 0.00
- EVOK 0.22
- MACD
- KLTO 0.00
- EVOK 0.10
- Stochastic Oscillator
- KLTO 0.00
- EVOK 97.01
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.